AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $43,000 | +38.7% | 52,027 | +9.8% | 0.00% | – |
Q2 2019 | $31,000 | – | 47,377 | +47277.0% | 0.00% | – |
Q1 2019 | $0 | -100.0% | 100 | -99.9% | 0.00% | -100.0% |
Q4 2018 | $190,000 | +25.8% | 119,288 | +127.8% | 0.00% | -85.7% |
Q1 2018 | $151,000 | +15000.0% | 52,372 | +7799.2% | 0.01% | – |
Q4 2017 | $1,000 | – | 663 | -12.8% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 760 | -89.0% | 0.00% | – |
Q1 2016 | $6,000 | +50.0% | 6,900 | +86.5% | 0.00% | – |
Q4 2015 | $4,000 | -20.0% | 3,700 | +7.9% | 0.00% | – |
Q2 2015 | $5,000 | – | 3,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
Caption Management, LLC | 855,200 | $701,000 | 0.04% |
Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |